Latest news with #CBDL
Yahoo
08-07-2025
- Business
- Yahoo
CBDL Announces Strategic Rollout on Vibe Performance Network, Elevating 8000MG Pain Cream to National Streaming Audiences
CBD Life Sciences Inc. (OTC:CBDL) expands its digital advertising arsenal through the Vibe Performance Network, positioning its flagship 8000MG Pain Cream in front of millions of engaged, wellness-focused viewers - unlocking massive revenue potential and long-term shareholder value in the booming CBD market. SCOTTSDALE, ARIZONA / / July 8, 2025 / CBD Life Sciences Inc. (OTC:CBDL), parent company of CBD Vault, is thrilled to announce a transformational leap in its national marketing strategy through integration with Vibe, a cutting-edge self-serve streaming TV advertising platform. This strategic move empowers CBDL to deliver targeted, data-driven campaigns across top-tier streaming platforms including Hulu, ESPN+, Roku, Discovery+, Tubi, and dozens of other premium outlets. As part of this rollout, CBDL will begin aggressively marketing its new 8000MG Pain Relief Cream - its most potent and in-demand product to date. Designed for athletes, chronic pain sufferers, and everyday individuals seeking fast, long-lasting relief, the 8000MG Pain Cream delivers unparalleled results - and now, it will reach a national audience with unmatched precision. "This initiative represents one of the most important and scalable steps forward in CBDL's history," said Lisa Nelson, President & CEO of CBDL. "With Vibe, we're not just buying ad space - we're owning the channel to our core audience. This technology allows us to place the right product in front of the right person at the right time. That means greater efficiency, greater visibility, and greater returns." The Vibe Advantage: Why This is a Major Inflection Point for CBDL CBDL's integration with the Vibe Performance Network gives the company unprecedented access to millions of health-conscious consumers across the U.S., including targeted audiences based on: Demographics (age, gender, income) Behavioral habits and content interests Zip-code level geographic targeting Engagement with wellness, recovery, fitness, and CBD-related content Unlike traditional TV or social media ads, Vibe campaigns are performance-optimized - allowing for real-time analytics, creative testing, and dynamic budget scaling, all while keeping advertising costs significantly lower than legacy platforms. Projected Revenue Impact and Market Positioning With this expanded visibility, CBDL is now positioned to unlock significant recurring revenue across both direct-to-consumer and wholesale channels. Based on historical customer conversion data and industry benchmarks, the 8000MG Pain Cream campaign alone could drive a projected 7-figure boost in annual revenue, with the potential to scale beyond as CBD Vault's product line continues to grow. This launch directly supports the company's mission of becoming a nationally recognized leader in natural wellness solutions, while laying the groundwork for future product launches using the same Vibe infrastructure. The global CBD market is forecasted to exceed $22 billion by 2030, and topical CBD products - like pain creams - are expected to see the highest CAGR within the industry at over 32.1% annually, according to Grand View Research. CBDL's powerful combination of product efficacy, consumer trust, and now digital ad precision, gives the company a major competitive edge as it scales nationwide. Investor Significance For current and prospective investors, this strategic deployment represents a material turning point in how the company markets, sells, and scales. By implementing a scalable, intelligent advertising ecosystem, CBDL is no longer reliant on outdated, inefficient marketing tactics - instead embracing the same programmatic tools used by Fortune 500 brands, tailored for the cannabis and wellness space. In essence, CBDL now controls its own national media pipeline, giving the company the ability to: Increase customer acquisition at lower costs Expand brand awareness across multiple demographics Support higher margins and longer customer lifetime value Launch future products into an already-primed national audience "This is more than just a campaign - it's infrastructure," added Nelson. "It's a system that can be used again and again to take new products to market, drive sales, and fuel consistent growth. It's a future-proof marketing engine." Vibe Platform Website : About CBD Life Sciences Inc. (CBDL) CBD Life Sciences Inc. is an innovative health and wellness company committed to the research, development, and distribution of premium cannabidiol (CBD) products through its core brand, CBD Vault. From topicals and tinctures to wellness beverages and skincare solutions, CBDL is building a portfolio of products designed for maximum efficacy, transparency, and consumer trust. Follow our social media for the latest updates!X: Contact: cbdvaultaz@ Stay Connected & Be the First to Try Our New Functional Mushroom Products! Mushroom Madness Instagram: Madness Website: Forward-Looking StatementsExcept for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements. Safe Harbor StatementThis release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements. Contact InformationLisa NelsonCEOcbdvaultaz@ SOURCE: CBD Life Sciences, Inc. View the original press release on ACCESS Newswire
Yahoo
11-06-2025
- Business
- Yahoo
CBD Life Sciences Inc. (CBDL) Reports 1,502.30% Revenue Increase from January to May 2025
Achieving a five-month revenue growth equivalent to an annualized rate exceeding 4,000%, as the booming CBD and mushroom supplement markets-projected to reach $30 billion and $15 billion respectively by 2028-fuel strong consumer demand and industry expansion. SCOTTSDALE, AZ / / June 11, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), a rising player in the natural health and wellness space, is proud to report a 1,502.30% increase in revenue from January through May of 2025 - a historic milestone for the company and a clear reflection of its expanding presence across retail, digital, and direct-to-consumer channels. This performance marks the company's strongest run of sustained month-over-month revenue growth to date and comes as CBDL shifts from a single-category CBD company to a diversified wellness brand with products designed for modern performance, recovery, and cognitive support. "This isn't just about selling more products - it's about becoming a health brand that consumers actively seek out," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "We've laid the foundation for scalable, repeatable success by combining innovation, access, and a strong identity in functional wellness." Key Drivers Of Growth National Retail Expansion & E-Commerce UbiquityCBDL's ability to meet consumers where they shop has been a major growth catalyst in 2025. The brand has successfully launched and scaled across high-traffic digital and physical platforms, including: Walmart Marketplace: Multiple SKUs now available online, including CBDL's best-selling 3000MG Pain Relief Cream and skin care formulations. DoorDash & Leafly: Products are accessible via local delivery in select markets, offering speed and convenience for customers. Groupon: Strategic limited-time wellness deals driving strong first-time purchase activity and consumer discovery. Shopify & Reddit: Expanded direct-to-consumer operations through Shopify, complemented by engagement in Reddit's niche wellness communities to boost brand awareness and customer acquisition. Product Innovation: Functional Wellness for the Modern Consumer CBDL's revenue growth closely aligns with its rapid innovation across plant-powered health categories. Beyond CBD, the company is gaining traction with functional and adaptogenic wellness products, including: Mushroom Smoothies & Brain Support Blends: Featuring natural cognitive enhancers like lion's mane, reishi, and cordyceps, these smoothies support memory, mental clarity, and energy - and are appearing in local coffee shops and health stores. Power+ Sexual Enhancement Supplement: A plant-based formula supporting male vitality, stamina, and circulation, quickly becoming a customer favorite. Adaptogenic Mushroom Supplements: Proprietary blends designed to support immune health, stress reduction, and overall daily balance, harnessing reishi, chaga, lion's mane, and ashwagandha. Strategic Vision & Responsible Growth CBDL continues to invest in infrastructure, brand visibility, and strategic partnerships to ensure long-term sustainable growth. While focusing on the U.S. market currently, the company is evaluating future expansion opportunities and additional retail collaborations. "Our focus remains on delivering real value through trusted products and accessible retail channels," added Nelson. "We are committed to building a wellness brand that serves consumers authentically while creating shareholder value." About CBD Life Sciences Inc. (CBDL) CBD Life Sciences Inc. is an Arizona-based health and wellness company focused on premium CBD, adaptogenic, and mushroom-based wellness products designed to support modern lifestyles. From pain relief to cognitive support and men's health, CBDL is committed to transparency, innovation, and accessibility. Follow our social media for the latest updates!X: Contact: cbdvaultaz@ Stay Connected & Be the First to Try Our New Functional Mushroom Products! Mushroom Madness Instagram: Madness Website: Forward-Looking StatementsExcept for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements. Safe Harbor StatementThis release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements. Contact InformationLisa NelsonCEOcbdvaultaz@ SOURCE: CBD Life Sciences Inc. View the original press release on ACCESS Newswire
Yahoo
28-05-2025
- Business
- Yahoo
CBD Life Sciences Inc. (CBDL) Announces New Powerful 500MG THC Delta-8 Gummy
With Delta-8 product revenue continuing to climb, CBDL introduces a lab-tested gummy formulation to meet surging demand in a market projected to exceed $2.1 billion by 2026. SCOTTSDALE, AZ / / May 28, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), a rising force in the cannabinoid wellness industry, is proud to announce the latest addition to its growing Delta-8 product lineup: a premium, lab-tested Delta-8 THC gummy, developed in-house to ensure consistency, potency, and quality at every step. Building on the success of its existing Delta-8 offerings, this new gummy marks another strategic milestone in CBDL's mission to dominate the cannabinoid edibles market. Crafted in a controlled lab environment, this new edible is designed for consumers who prioritize quality, effectiveness, and a clean, smooth Delta-8 experience. "We've already seen strong performance across our Delta-8 line, and this gummy is a direct response to customer demand for more convenient, enjoyable, and effective ways to experience its benefits," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "As always, we're delivering a product that's backed by science, produced in-house, and driven by results." Delta-8 THC: Expanding the Future of Functional WellnessUnlike traditional Delta-9 THC, Delta-8 offers a milder, clearer psychoactive experience - making it a preferred option for wellness seekers, first-time users, and individuals looking for a balanced high without anxiety. CBDL's newly formulated Delta-8 gummies are not just about effect - they're designed to deliver real therapeutic value. Below is a breakdown of the core wellness benefits supported by research and consumer feedback: Pain Relief • Engages the endocannabinoid system to help regulate pain• May reduce inflammation that contributes to chronic discomfort Anxiety & Stress Support • Natural calming effects to help manage daily stress and reduce anxiety• Promotes overall mood balance without sedation Nausea Control • Anti-emetic potential makes it a powerful option for those undergoing chemotherapy or other nausea-inducing treatments Appetite Stimulation • Ideal for individuals with appetite loss or dietary imbalances related to health conditions Neuroprotective Potential • Early research suggests Delta-8 THC may contribute to long-term brain health through its interaction with CB1 receptors Made In-House. Backed by Lab many mass-produced gummies on the market, CBDL maintains full control over every phase - from formulation to packaging - in its in-house manufacturing facility. Each batch is independently lab-tested to guarantee purity, potency, and compliance, giving consumers complete confidence in what they're consuming. Strategic Growth for Shareholders & StakeholdersDelta-8 THC products have already proven to be one of CBDL's strongest performing categories, and this launch further solidifies the company's aggressive expansion in the high-growth cannabinoid edible space. The market for Delta-8 continues to gain national momentum, with sales projections showing compound annual growth that far outpaces many traditional supplement sectors. "This gummy is just one part of a much larger product ecosystem we're building - focused on in-demand cannabinoids, real health outcomes, and market scalability," said Nelson. Product Details • Product: Delta-8 THC Gummy• Type: Vegan, In-House Formulated, Lab-Tested• MG per Gummy: 500MG• Availability: Launching via Flavors: Blue Razz & Strawberry About CBD Life Sciences Inc. (CBDL)CBD Life Sciences Inc. is a vertically integrated health and wellness company focused on cannabinoid innovation. With a robust pipeline of CBD, Delta-8, and other hemp-derived formulations, CBDL operates across direct-to-consumer, retail, and wholesale channels - including recent distribution on Walmart Marketplace and additional platforms coming soon. Follow our social media for the latest updates!X: Contact: cbdvaultaz@ Stay Connected & Be the First to Try Our New Functional Mushroom Products! Mushroom Madness Instagram: Mushroom Madness Website: Forward-Looking StatementsExcept for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements. Safe Harbor StatementThis release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements. Contact InformationLisa NelsonCEOcbdvaultaz@ SOURCE: CBD Life Sciences Inc. View the original press release on ACCESS Newswire Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
06-05-2025
- Business
- Yahoo
CBD Life Sciences Inc. (CBDL) Announces New Manufacturing Deal With A Southwest-Based Company
Strategic alliance positions CBDL for aggressive national growth through 100+ retail locations and new premium product lines SCOTTSDALE, AZ / ACCESS Newswire / May 6, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), a leading innovator in the CBD health and wellness space, is proud to announce a new strategic manufacturing partnership with Jeannie in a Bottle, a fast-growing Arizona-based CBD company with a national retail footprint. This powerful collaboration will see CBDL formulating and manufacturing top-tier CBD products for Jeannie in a Bottle - a company with proven market traction and shelf presence in over 100 gas stations and convenience stores across the United States. The deal expands CBDL's manufacturing portfolio while opening the door to high-volume, recurring product orders tied to Jeannie's established consumer base and retail distribution network. Under this agreement, CBDL will take full control of the production, packaging, and labeling of a specialized line of high-potency CBD products exclusively for Jeannie in a Bottle - a strategic move expected to significantly boost CBDL's nationwide revenue stream through consistent retail orders and brand expansion. "This partnership is a win-win - not just for CBDL and Jeannie in a Bottle, but for shareholders and customers alike," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "We're stepping into a high-velocity retail environment with a proven brand, and bringing our own formulation and production strengths to the table. This is the kind of alignment that accelerates revenue, reputation, and results." With CBDL managing product development, formulation, and manufacturing, Jeannie in a Bottle is positioned to scale its product offerings faster than ever - offering convenience store customers across the country consistent, compliant, and highly effective CBD wellness solutions. Why This Deal Matters for CBDL Investors:
Associated Press
22-04-2025
- Health
- Associated Press
CBD Life Sciences Inc. (CBDL) Announces Groundbreaking 100MG Full Spectrum CBD Gummy Geared Toward Mental Health & Focus
With the global CBD market expected to exceed $60 billion by 2030, and the mental wellness industry surging past $500 billion, CBD Life Sciences Inc. (OTC:CBDL) is strategically positioning itself at the center of two of the fastest-growing markets in modern health. SCOTTSDALE, AZ / ACCESS Newswire / April 22, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL) a leader in cannabinoid-driven health innovation - proudly announces the launch of its most anticipated product to date: a high-dosage 100MG Full Spectrum CBD Gummy, meticulously formulated to support mental health, daily focus, and emotional well-being. Available in mouth-watering Crisp Green Apple and Wild Blueberry flavors, this isn't your average CBD gummy. It's a next-generation wellness tool - designed not only to relax the body but to sharpen the mind. Crafted with full-spectrum cannabinoids, these gummies are being positioned as a natural ally in the pursuit of mental clarity, balance, and daily productivity. 'Mental health isn't a trend - it's a global crisis. And people are tired of band-aid solutions,' said Lisa Nelson, President & CEO of CBD Life Sciences Inc. 'This product was built to empower people who want to feel better and function better - without the side effects of traditional pharmaceuticals. It's a powerful, natural alternative that speaks directly to the stress, anxiety, and attention struggles millions face every day.' Lab tested and verified with Certificates of Analysis (COAs), this 100MG gummy represents the company's deepest push yet into the lucrative mental wellness category. Unlike many low-dose competitors, CBDL's bold formulation is made for people who need real results - entrepreneurs, creatives, students, parents, and professionals looking to stay in control of their mood and mindset. Early conversations with several wellness clinics and mental health centers are already in progress, exploring how this high-potency gummy could be integrated into patient routines. While no formal agreements have been made, the demand is clear: health professionals are actively seeking natural, high-quality, lab-verified CBD options to complement modern mental wellness protocols. CBDL is rapidly building a portfolio that taps into high-value niches: from pain relief and nano-enhanced beverages to functional CBD coffee creamers and now, this cutting-edge product for mental clarity. The company's ability to stay ahead of trends and deliver results has attracted attention from both investors and the wellness industry. 'We're not trying to follow the market - we're reshaping it,' Nelson added. 'With this launch, we're doubling down on our belief that the future of wellness lies in functional, focused, and effective cannabinoid products.' This release is a bold statement to shareholders and the industry: CBD Life Sciences Inc. is serious about mental health. The company's momentum continues to build, and with this new launch, they're inviting wellness professionals, retail buyers, and everyday users to experience the next level of what CBD can offer. The 100MG Mental Health Gummies are available now, with full lab reports and wholesale interest forms available on the company's website. For product information, COAs, or wholesale inquiries, please visit About CBD Life Sciences Inc. CBD Life Sciences Inc. (CBDL) is a leading innovator in the wellness and alternative health sector, specializing in high-quality CBD and functional mushroom products designed to enhance well-being. With a commitment to scientific research and consumer safety, CBDL continues to push the boundaries of holistic health solutions, creating opportunities for exponential growth in a rapidly evolving market. Follow our social media for the latest updates! X: Instagram: IR Contact: [email protected] Stay Connected & Be the First to Try Our New Functional Mushroom Products! Mushroom Madness Instagram: Mushroom Madness Website: Forward-Looking Statements Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements. Safe Harbor Statement This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements. Contact Information Lisa Nelson CEO [email protected] 4802091720 SOURCE: CBD Life Sciences, Inc. press release
